Furthermore, the APOE ε2/ε2 genotype displayed a higher risk of cancer development compared to APOE ε2/ε3, particularly in patients with advanced stages of lung cancer, suggesting a potential association with cancer progression stages. The gene discussed is APOE; the disease is lung carcinoma.